LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Paraoxonase 1 and 2 gene variants and the ischemic stroke risk in Gran Canaria population: an association study and meta-analysis.

    Rodríguez-Esparragón, Francisco / López-Fernández, Juan Carlos / Buset-Ríos, Nisa / García-Bello, Miguel A / Hernández-Velazquez, Erika / Cappiello, Laura / Rodríguez-Pérez, José Carlos

    The International journal of neuroscience

    2017  Volume 127, Issue 3, Page(s) 191–198

    Abstract: Purpose of the study: The present study aims to evaluate the relationship between rs662 (Gln(Q)192Arg(R)) and rs854560 (L55M) and the rs7493 (S311C) in the paraoxonase genes and ischemic stroke (IS) in the population of Gran Canaria (Canary Islands). ... ...

    Abstract Purpose of the study: The present study aims to evaluate the relationship between rs662 (Gln(Q)192Arg(R)) and rs854560 (L55M) and the rs7493 (S311C) in the paraoxonase genes and ischemic stroke (IS) in the population of Gran Canaria (Canary Islands). The association with stroke was also evaluated using systematic review and meta-analysis.
    Methods: A total of 129 IS patients and 176 age and gender matched controls were enrolled. For meta-analysis, eligible studies were identified through search in public databases.
    Results: In multivariate regression analysis only the PON2 S311C variant showed to be an independent predictor of IS (OR = 0.093, 95% CI: 0.014-0.627). Overall, no significant association was found between L55M and IS when all studies were pooled nor by subgroup analysis by ethnicity. Gln192Arg showed a modest risk for IS in the global and in Asian population but with high heterogeneity among studies. A modest risk under a dominant inheritance model was found for the S311C variant with an overall random effect OR of 1.004 (95% CI: 1.00-1.35). There was strong evidence of heterogeneity among studies (  p = 0.0097, I
    Conclusions: The overall analysis shows a significant contribution of the rs662 variant to IS risk. We found that the CC genotype of the PON2 S311C polymorphism is a risk factor for IS. Results of the meta-analysis partially support this conclusion.
    MeSH term(s) Acetylcholinesterase/blood ; Adult ; Aged ; Aryldialkylphosphatase/genetics ; Brain Ischemia/complications ; Community Health Planning ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease/genetics ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide/genetics ; Prospective Studies ; Spain/epidemiology ; Statistics, Nonparametric ; Stroke/blood ; Stroke/enzymology ; Stroke/etiology ; Stroke/genetics
    Chemical Substances Acetylcholinesterase (EC 3.1.1.7) ; Aryldialkylphosphatase (EC 3.1.8.1) ; PON1 protein, human (EC 3.1.8.1) ; PON2 protein, human (EC 3.1.8.1)
    Language English
    Publishing date 2017-03
    Publishing country England
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 3061-2
    ISSN 1563-5279 ; 1543-5245 ; 0020-7454
    ISSN (online) 1563-5279 ; 1543-5245
    ISSN 0020-7454
    DOI 10.3109/00207454.2016.1165675
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Homocysteinylated protein levels in internal mammary artery (IMA) fragments and its genotype-dependence. S-homocysteine-induced methylation modifications in IMA and aortic fragments.

    Rodríguez-Esparragón, Francisco / Serna-Gómez, Jaime Alberto / Hernández-Velázquez, Erika / Buset-Ríos, Nisa / Hernández-Trujillo, Yaridé / García-Bello, Miguel A / Rodríguez-Pérez, José C

    Molecular and cellular biochemistry

    2012  Volume 369, Issue 1-2, Page(s) 235–246

    Abstract: The resistance of internal mammary artery (IMA) toward atherosclerosis is not well understood. In plasma, homocysteine (Hcy) occurs in reduced, oxidized, homocysteine thiolactone and a component of proteins as a result of N- or S-homocysteinylation. We ... ...

    Abstract The resistance of internal mammary artery (IMA) toward atherosclerosis is not well understood. In plasma, homocysteine (Hcy) occurs in reduced, oxidized, homocysteine thiolactone and a component of proteins as a result of N- or S-homocysteinylation. We evaluated S/N-homocysteinylated protein levels in IMA fragments of patients undergoing coronary artery bypass grafting, and whether they were affected by genetic common variants. We tested whether tHcy, Hcy-S-protein levels, genotypes or Hcy-induced methylation modifications were related to differences in iNOS, Ddah2, and eNOS gene expression between territories. A small percentage of Hcy-S-proteins were found in IMA fragments. The Mthfr C677T (rs1801133) and Pon-1 Leu55Met (rs854560) variants were associated with Hcy-S-proteins. We observed a gradual difference according to Hcy-S-protein levels in the methylation degree of the Ddah2 gene promoter in aortic, but not in IMA, fragments. No correlation between the degree of methylation and the Ddah2 gene expression levels was found in both types of analyzed fragments. Total Hcy but not Hcy-S-proteins correlated with iNOS promoter methylation. Analyzed variants seem to contribute to the in vivo Hcy binding properties to IMA. The contribution of the Hcy-derived methylation modifications to Ddah2 and eNOS gene expression seems to be tissue-specific and independent of the Ddah2/ADMA/eNOS pathway. Hcy-derived methylation modifications to the iNOS gene promoter contribute to a lesser extent to iNOS gene expression.
    MeSH term(s) Aged ; Amidohydrolases/genetics ; Amidohydrolases/metabolism ; Aorta/enzymology ; Atherosclerosis/enzymology ; Atherosclerosis/genetics ; Coronary Artery Bypass ; Female ; Gene Expression ; Genotype ; Homocysteine/genetics ; Homocysteine/metabolism ; Humans ; Male ; Mammary Arteries/enzymology ; Methylation ; Middle Aged ; Nitric Oxide Synthase Type II/genetics ; Nitric Oxide Synthase Type II/metabolism ; Nitric Oxide Synthase Type III/genetics ; Nitric Oxide Synthase Type III/metabolism ; Polymorphism, Genetic ; Promoter Regions, Genetic
    Chemical Substances Homocysteine (0LVT1QZ0BA) ; NOS2 protein, human (EC 1.14.13.39) ; NOS3 protein, human (EC 1.14.13.39) ; Nitric Oxide Synthase Type II (EC 1.14.13.39) ; Nitric Oxide Synthase Type III (EC 1.14.13.39) ; Amidohydrolases (EC 3.5.-) ; dimethylargininase (EC 3.5.3.18)
    Language English
    Publishing date 2012-07-14
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 184833-1
    ISSN 1573-4919 ; 0300-8177
    ISSN (online) 1573-4919
    ISSN 0300-8177
    DOI 10.1007/s11010-012-1387-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top